UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Novel mechanisms of resistance to EGFR inhibitory drugs in non-small cell lung cancer

Cowell, CF; (2012) Novel mechanisms of resistance to EGFR inhibitory drugs in non-small cell lung cancer. Doctoral thesis , UCL (University College London). Green open access

[img]
Preview
PDF
PhDThesisFinalNov5.pdf
Available under License : See the attached licence file.

Download (11MB)
[img] Excel Spreadsheet (Appendix 1)
Appendix1_residualZscores.xlsx
Available under License : See the attached licence file.

Download (10MB)
[img] Excel Spreadsheet (Appendix 2)
Appendix 2 _Top2.5%Screen1_Top5%Screen2.xlsx
Available under License : See the attached licence file.

Download (63kB)
[img] Excel Spreadsheet (Appendix 3)
Appendix3_Deconvolution.xlsx
Available under License : See the attached licence file.

Download (84kB)

Abstract

EGFR activating mutations are present in 10-40% of non-small cell lung cancer. Such mutations render tumour cells sensitive to EGFR tyrosine kinase inhibitors (EGFR TKIs), with responses of up to 80% in populations selected for the presence of an activating mutation. Unfortunately, almost all patients develop resistance after about a year. Clinically described mechanisms of resistance include the presence of a secondary mutation (T790M) in EGFR which prevents EGFR TKIs binding to the EGF receptor, and amplification MET which permits survival signalling via the ERBB3 receptor. However in 30% of cases, the mechanism of acquired resistance to EGFR TKIs is still unknown. My aim was to carry out a genome-wide siRNA screen to identify novel mechanisms of resistance to EGFR TKIs. I identified two genes that have not been implicated in EGFR TKI resistance previously, NF1 and DEPTOR, which are negative regulators of RAS and mTOR respectively. Depletion of NF1 or DEPTOR leads to increased resistance to EGFR TKIs via upregulation of MAPK signalling by direct and indirect mechanisms.

Type: Thesis (Doctoral)
Title: Novel mechanisms of resistance to EGFR inhibitory drugs in non-small cell lung cancer
Open access status: An open access version is available from UCL Discovery
Language: English
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
URI: http://discovery.ucl.ac.uk/id/eprint/1370656
Downloads since deposit
1,373Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item